Compugen Ltd. - Ordinary Shares (CGEN) Social Stream
COMPUGEN LTD (CGEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CGEN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 5 | $28 | $16 | $21.333 | $1.81 | 1078.62% |
| 2021-11-15 | 6 | $28 | $16 | $21.333 | $1.81 | 1078.62% |
| 2021-12-10 | 6 | $28 | $16 | $21 | $1.81 | 1060.22% |
| 2022-02-04 | 6 | $25 | $14 | $18.666 | $1.81 | 931.27% |
| 2022-02-25 | 6 | $25 | $14 | $16.666 | $1.81 | 820.77% |
| 2022-04-27 | 5 | $25 | $9 | $15 | $1.81 | 728.73% |
| 2022-05-17 | 6 | $14 | $9 | $12.166 | $1.81 | 572.15% |
| 2022-08-04 | 6 | $14 | $9 | $11.833 | $1.81 | 553.76% |
| 2022-08-08 | 7 | $14 | $2 | $8.571 | $1.81 | 373.54% |
| 2022-08-23 | 7 | $14 | $2 | $7.142 | $1.81 | 294.59% |
| 2022-10-14 | 7 | $14 | $2 | $7 | $1.81 | 286.74% |
| 2022-11-15 | 7 | $14 | $2 | $6.428 | $1.81 | 255.14% |
| 2023-01-05 | 8 | $14 | $1 | $7.125 | $1.81 | 293.65% |
| 2023-02-08 | 6 | $13 | $0.5 | $6.071 | $1.81 | 235.41% |
| 2023-02-28 | 7 | $13 | $0.5 | $6.071 | $1.81 | 235.41% |
| 2023-03-06 | 7 | $13 | $0.5 | $5.642 | $1.81 | 211.71% |
| 2023-06-02 | 5 | $13 | $3 | $6.2 | $1.81 | 242.54% |
| 2023-11-07 | 4 | $13 | $3 | $6.75 | $1.81 | 272.93% |
| 2023-12-20 | 3 | $7 | $3 | $4.666 | $1.81 | 157.79% |
The Trend in the Analyst Price Target
Over the past 17 months, CGEN's average price target has gone down $6.83.
Over the past 45 weeks, CGEN's average upside potential has been 547.57%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-28 | 7 | 13 | 0.5 | 6.071 | 0.790 | 668.48% |
| 2023-06-02 | 5 | 13 | 3.0 | 6.200 | 1.050 | 490.48% |
| 2023-06-02 | 4 | 13 | 3.0 | 6.200 | 1.050 | 490.48% |
| 2023-11-07 | 4 | 7 | 3.0 | 4.666 | 0.682 | 584.16% |
| 2023-12-20 | 3 | 7 | 4.0 | 5.000 | 1.850 | 170.27% |
CGEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 20 months, CGEN's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- COMPUGEN LTD's upside potential (average analyst target price relative to current price) is greater than 2292.1% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, COMPUGEN LTD's average analyst price target is greater than 284.22% of them.
- CGEN has a lower variance in analysts' estimates than -2042.18% of all US stocks.
- COMPUGEN LTD's number of analysts covering the stock is greater than 1706.4% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COMPUGEN LTD are ONVO, XTNT, and ADMA.
View All Top Stocks by Price Target
Make investment decisions regarding CGEN using the data that counts. Try POWR Ratings for free.